首站-论文投稿智能助手
典型文献
A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression
文献摘要:
Tumor-related PD-L2 expression is associated with the clinical efficacy of PD-1/PD-L1 blockade therapy.PD-L2-specific imaging can help selecting patients for appropriate immunotherapy.In this study,a PD-L2-targeting peptide(PDP2)was screened by the one-bead one-compound combinatorial library approach.Using the retro-inverso D-peptide of PDP2(RD-PDP2)and PEGylation strategies,we developed a novel Tc-99m-labeled PD-L2-targeting peptide as a SPECT tracer(99mTc-PEG6-RD-PDP2)for imaging of tumor PD-L2 expression.The radiolabeling yield of 99mTc-PEG6-RD-PDP2 was greater than 95%by the stan-dard HYNIC/tricine/TPPTS labeling procedure.99mTc-PEG6-RD-PDP2 displayed high PD-L2-binding speci-ficity both in vitro and in vivo.SPECT/CT imaging with 99mTc-PEG6-RD-PDP2 showed that the A549-PD-L2 tumors were clearly visualized,whereas the signals in PD-L2-negative A549 tumors were much lower.In vivo blocking study suggested that the tumor uptake of 99mTc-PEG6-RD-PDP2 was PD-L2 specifically mediated.99mTc-PEG6-RD-PDP2 is a promising SPECT probe for the non-invasive imaging of tumor PD-L2 expression and has a great potential in guiding the anti-PD-1 or anti-PD-L1 immunotherapy of cancer.
文献关键词:
作者姓名:
Qi Luo;Yunwei Zhang;Zihua Wang;Yining Sun;Linqing Shi;Yue Yu;Jiyun Shi;Zhiyuan Hu;Fan Wang
作者机构:
Guangzhou Laboratory,Guangzhou 510005,China;Medical Isotopes Research Center and Department of Radiation Medicine,State Key Laboratory of Natural and Biomimetic Drugs,School of Basic Medical Sciences,Peking University,Beijing 100191,China;Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases,School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China;Key Laboratory of Protein and Peptide Pharmaceuticals,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Standardization and Measurement for Nanotechnology,CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,Beijing 100190,China
引用格式:
[1]Qi Luo;Yunwei Zhang;Zihua Wang;Yining Sun;Linqing Shi;Yue Yu;Jiyun Shi;Zhiyuan Hu;Fan Wang-.A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression)[J].中国化学快报(英文版),2022(07):3497-3501
A类:
PEG6,PDP2,inverso,radiolabeling,tricine,TPPTS
B类:
novel,peptide,probe,99mTc,RD,molecular,imaging,L2,expression,Tumor,related,associated,clinical,efficacy,L1,blockade,help,selecting,patients,appropriate,immunotherapy,In,this,study,targeting,was,screened,by,one,bead,compound,combinatorial,library,approach,Using,retro,PEGylation,strategies,developed,labeled,SPECT,tracer,yield,greater,than,stan,dard,HYNIC,procedure,displayed,high,binding,ficity,both,vitro,vivo,showed,that,A549,tumors,were,clearly,visualized,whereas,signals,negative,much,lower,blocking,suggested,uptake,specifically,mediated,promising,invasive,has,potential,guiding,anti,cancer
AB值:
0.38387
相似文献
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Preclinical evaluation and pilot clinical study of[18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
Kongzhen Hu;Junqi Li;Lijuan Wang;Yong Huang;Li Li;Shimin Ye;Yanjiang Han;Shun Huang;Hubing Wu;Jin Su;Ganghua Tang-Department of Nuclear Medicine,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;Shenzhen International Institute for Biomedical Research,Shenzhen 518116,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen 518116,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510182,China
Cooperative coordination-mediated multi-component self-assembly of"all-in-one"nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer
Xiaojie Chen;Xudong Fan;Yue Zhang;Yinghui Wei;Hangsheng Zheng;Dandan Bao;Hengwu Xu;Ji-Gang Piao;Fanzhu Li;Hongyue Zheng-School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Dermatology&Cosmetology,The First Affiliated Hospital of Zhejiang Chinese Medical University(Zhejiang Provincial Hospital of Traditional Chinese Medicine),Hangzhou 310006,China;Department of Pharmacy,Jinhua People's Hospital,Jinhua 321000,China;Academy of Chinese Medical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Libraries of Zhejiang Chinese Medical University,Zhejiang Chinese Medical University,Hangzhou 310053,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun;Yao Cheng;Xiaojia Liu;Gefei Wang;Wenjian Min;Xiao Wang;Kai Yuan;Yi Hou;Jiaxing Li;Haolin Zhang;Haojie Dong;Liping Wang;Chenguang Lou;Yanze Sun;Xinmiao Yu;Hongbin Deng;Yibei Xiao;Peng Yang-State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Beijing Institute of Clinical Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Physics,Chemistry and Pharmacy,University of Southern Denmark,Campusvej 55,5230 Odense,Denmark;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
Albumin-binding lipid-aptamer conjugates for cancer immunoimaging and immunotherapy
Longlong Tian;Ming Shao;Yimou Gong;Yu Chao;Ting Wei;Kai Yang;Qian Chen;Zhuang Liu-Institute of Molecular Medicine,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Frontiers Science Center for Rare Isotopes,Lanzhou University,Lanzhou 730000,China;Institute of Functional Nano and Soft Materials(FUNSOM),Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices,Soochow University,Suzhou 215123,China;State Key Laboratory of Radiation Medicine and Protection,School of Radiation Medicine and Protection&School for Radiological and Interdisciplinary Sciences(RAD-X),Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,Soochow University,Suzhou 215123,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。